Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 209.00
Bid: 208.00
Ask: 215.00
Change: -6.00 (-2.79%)
Spread: 7.00 (3.365%)
Open: 212.00
High: 214.00
Low: 207.00
Prev. Close: 215.00
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: European large-caps rise on eve of Fed decision

Tue, 19th Mar 2024 16:57

(Alliance News) - Blue-chip stock prices in Europe closed higher on Tuesday, showing little signs of nerves ahead of Wednesday's Federal Reserve decision and UK inflation reading.

A key week for central bank decisions kicked off with a historic hike by the Bank of Japan, though that failed to spur on the yen.

The FTSE 100 index rose 15.75 points, 0.2%, at 7,738.30. The FTSE 250 ended down 53.72 points, 0.3%, at 19,432.81, and the AIM All-Share fell 1.07 points, 0.2%, at 735.56.

The Cboe UK 100 rose 0.2% to 774.76, the Cboe UK 250 fell 0.3% to 16,869.44, and the Cboe Small Companies closed up 0.3% at 14,818.14.

In European equities on Tuesday, the CAC 40 in Paris ended up 0.7%, while the DAX 40 in Frankfurt added 0.3%.

In New York, the Dow Jones Industrial Average was up 0.6% at the time of the closing bell in Europe. The S&P 500 rose 0.2%, though the Nasdaq Composite was fractionally lower.

The pound was quoted at USD1.2719 at the time of the London equities close, a touch lower from USD1.2722 on Monday. The euro stood at USD1.0860, down against USD1.0877.

The US Federal Reserve is expected to once again leave interest rates unmoved on Wednesday, while also dialling back cut expectations in its latest dot-plot.

The US central bank announces its latest interest rate decision at 1800 GMT on Wednesday. A press conference with Chair Jerome Powell follows shortly after. Threatening to hog the spotlight, the latest summary of economic projections will be revealed alongside the decision. The SEP features the dot-plot of interest rate expectations of policymakers.

In December, the chart suggested the Fed will enact three cuts this year.

With the CME FedWatch Tool suggesting a 99% chance the central bank holds in March, a 93% likelihood it does the same in May, and hope of a June cut dwindling, the December plot could be hawkishly re-jigged.

"The US data continue to come in mostly firmer and despite Powell's recent dovish testimony before Congress, most Fed officials remain very cautious about easing too soon. We believe that the current market easing expectations for the Fed still need to adjust. When they do, the dollar should gain further. Last week's inflation data sparked the start of this process and the FOMC decision tomorrow will be key for the continuation of this move," Brown Brothers Harriman analysts commented.

The Bank of England will also be in focus this week, with a UK inflation reading to come on Wednesday, the eve of Threadneedle Street's interest rate decision.

Ebury analyst Matthew Ryan commented: "Data on both UK inflation and wages has surprised to the downside since the last meeting, although both remain far too high for comfort and insufficient to warrant a change in guidance. There will be no Monetary Policy Report or press conference, but the statement will likely stress that policy will remain restrictive, with rates to be kept 'under review'.

"The key for markets will be the voting pattern among committee members. We are pencilling in another unprecedented three-way split, whereby one votes for a cut, two for a hike and the rest for no change. We see a distinct possibility, however, of a dovish swing, whereby one or both of the hawks shift their allegiance in favour of the majority. With markets not fully pricing in the first rate cut until August, this could pave the way for some weakness in sterling, as investors mull a start to easing at the bank's June meeting."

According to FXStreet cited consensus, the rate of consumer price inflation in the UK is forecast to have ebbed to 3.6% in February, from 4.0% in January.

The data is released at 0700 GMT. Before the Fed decision at 1800 GMT, Wednesday's economic calendar has a eurozone consumer confidence reading at 1500 GMT.

Against the yen, the dollar was trading at JPY150.76 at the time of the European equities close, jumping from JPY149.12.

In a long-anticipated move, the Bank of Japan on Tuesday ended its negative interest rate policy.

The Japanese central bank said it judged its monetary easing policy and yield curve control programme have "fulfilled their roles". It raised its short-term policy rate to a range of 0.0% to 0.1%, from minus 0.1% previously. The move marks the BoJ's first interest rate hike in 17 years.

XTB analyst Kathleen Brooks commented: "Right now, the market thinks that it could be one and done for the BoJ, however, with such large increases in wages, the BoJ could be forced into hiking again."

In the FTSE 100, Unilever rose 3.1%, after it said it plans to spin off its ice cream business and cut 7,500 jobs as it picks up the pace of its reorganisation plans.

The owner of Marmite, Dove soaps and Domestos announced the move alongside proposals to accelerate its "growth action plan".

Unilever intends to launch a comprehensive productivity programme which it anticipated will deliver total cost savings of around EUR800 million over the next three years, more than offsetting estimated operational dis-synergies from spinning off the ice cream business.

The changes are expected to impact around 7,500 jobs, with total restructuring costs now anticipated to be around 1.2% of group turnover for the next three years, up from around 1% of turnover previously guided.

Unilever, which owns five of the top 10 selling global ice cream brands including Wall's, Magnum and Ben & Jerry's, said the separation of ice cream will assist in the implementation of the GAP.

PureTech jumped 8.1%.

The Boston, Massachusetts-based biotherapeutics company said it plans to return USD100 million to shareholders with a tender offer, starting after it publishes its annual report in April.

Crest Nicholson slumped 9.1%, after it warned it could face a GBP15 million charge after uncovering defects in some legacy projects.

The Surrey, England-based housebuilder said the issues related to four sites that were completed prior to 2019 when the group closed its regeneration and London divisions.

Crest Nicholson said these sites will require remediation over the next three years at an estimated cost of up to GBP15 million.

Sofa retailer DFS fell 6.0%. It said pretax profit fell to GBP900,000 in the 26 weeks that ended December 24 from GBP6.8 million a year before, as revenue declined by 7.2% to GBP505.1 million from GBPP544.5 million.

In response, DFS cut its interim dividend by 27% to 1.1p from 1.5p.

Looking ahead, it lowered its financial 2024 adjusted pretax profit guidance to between GBP20 million and GBP25 million, which would be down from GBP30.6 million in financial 2023.

Revenue is expected to be between GBP1.00 billion and GBP1.02 billion, which would be down from GBP1.09 billion.

"After a solid start to January, market demand has weakened significantly over the last two months," DFS said, noting order volumes are down 16% on a year before.

Brent oil was quoted at USD87.19 a barrel late in London on Tuesday, up from USD86.27 late Monday. Gold fetched at USD2,155.26 an ounce on Tuesday, lower against USD2,158.93 late Monday.

Oil majors Shell and BP, among the FTSE 100's largest constituents, rose 1.3% and 1.0%. Conversely, gold miner Fresnillo fell 3.5%.

ActivTrades analyst Ricardo Evangelista commented: "The retreat in the precious metal's value is tied to the strengthening of the US dollar. This morning, the greenback reached a multi-week peak, signalling market anticipation of a hawkish stance from the Federal Reserve, potentially bolstering the dollar's standing. As the US central bank concludes its March meeting tomorrow, traders anticipate interest rates will remain unchanged. Nevertheless, persistent inflation and the robustness of the US economy suggest that the Fed may uphold its tight monetary policy for an extended period. In this context, the dollar's risk remains skewed to the upside, limiting the potential for gold price appreciation."

Wednesday's UK corporate calendar has annual results from insurer Prudential and a trading statement from financial services firm Investec.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
16 Oct 2019 13:42

FTSE 250 movers: PureTech falls, Mediclinic climbs

(Sharecast News) - London's FTSE 250 was 0.31% lower at 19,134.998 in afternoon trade on Wednesday, as PureTech Health led the index lower.

Read more
4 Oct 2019 18:08

Jupiter UK Growth Assets Fall On Thomas Cook Pain; Remains Upbeat

Jupiter UK Growth Assets Fall On Thomas Cook Pain; Remains Upbeat

Read more
2 Oct 2019 17:35

PureTech Health Takes Final 10% Stake In Ariya Therapeutics

PureTech Health Takes Final 10% Stake In Ariya Therapeutics

Read more
2 Oct 2019 08:12

PureTech secures remaining 10% of Ariya Therapeutics

(Sharecast News) - PureTech Health on Wednesday acquired the remaining 10% of Ariya Therapeutics, with the now wholly-owned subsidiary set to be renamed as PureTech LYT.

Read more
9 Sep 2019 13:04

PureTech Chair Ito Resigns Amid MIT Media Lab Epstein Funding Scandal

(Alliance News) - PureTech Health PLC said Monday Chair Joichi Ito stepped down from the company amid "circumstances related to the MIT Media Lab", with Non-Executive Director Viehbacher

Read more
20 Aug 2019 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 21 August Charter Court Financial ServicesHalf Year ResultsOnesavings Year Year Year 22

Read more
17 Jul 2019 11:47

PureTech Health Acquires LYT-100 Product Candidate To Treat Lymphedema

(Alliance News) - PureTech Health PLC on Wednesday said it has acquired LYT-100 for the potential treatment of lymphatic and immunofibrotic diseases.LYT-100 was acquired from an undisclosed

Read more
11 Jul 2019 08:18

PureTech Health Mulling Listing ADSs On Nasdaq Alongside London

(Alliance News) - PureTech Health PLC is exploring a listing of American depositary shares on the Nasdaq exchange in New York, it said Thursday, which would be backed up by an offering of new a on

Read more
9 Jul 2019 12:55

PureTech Health Receives US Patent For Immuno-Oncology Candidate

(Alliance News) - PureTech Health PLC said Tuesday the US Patent & Trademark Office has issued a patent covering the company's internal immuno-oncology product candidate, said the patent a

Read more
3 Jul 2019 12:48

PureTech Health's Karuna Raises USD103 Million In US IPO

(Alliance News) - PureTech Health PLC said Wednesday that affiliate Karuna Therapeutics Inc has raised USD102.6 million in its initial public offering on the Nasdaq Global Market.PureTech a

Read more
28 Jun 2019 13:23

PureTech Health Investee Karuna Therapeutics Joins Nasdaq

(Alliance News) - PureTech Health PLC affiliate Karuna Therapeutics Inc is to raise nearly USD90 million in its listing on the Nasdaq, PureTech said Friday.Karuna will offer 5.6 million new

Read more
13 Jun 2019 15:19

Positive Results From PureTech Affiliate Male Pattern Hair Loss Study

(Alliance News) - PureTech Health PLC on Thursday said its Follica affiliate is planning a pivotal study after positive data in patients with male pattern hair loss.Shares in company were a

Read more
3 Jun 2019 14:19

PureTech Health Affiliate Karuna To List On Nasdaq (ALLIPO)

LONDON (Alliance News) - PureTech Health PLC on Monday said that its affiliate, Karuna Therapeutics Inc, has filed a public registration statement with the US Securities & Exchange Commission

Read more
22 May 2019 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 23 MayGoCompare.comIntertekInstemAlliance InternationalJKX

Read more
20 May 2019 11:24

Encouraging GS500 Prototype Study By PureTech Affiliate Gelesis

LONDON (Alliance News) - Biopharmaceutical firm PureTech Health PLC on Monday said its Gelesis affiliate has announced "promising clinical data" from a study of a GS500 prototype in has

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.